Lek

Type
Business expansion
Country
Slovenia
Region
Slovenija; Zahodna Slovenija; Osrednjeslovenska
Location of affected unit(s)
Mengeš
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
100 jobs
Number of planned job creations
Job creation
Announcement Date
21 January 2016
Employment effect (start)
22 January 2016
Foreseen end date
22 June 2016

Description

Pharmaceutical company Lek, which is part of the global generics leader Sandoz (Novartis), has enlarged its bio-pharmaceutical development centre in Mengeš, near Ljubljana. The investment in new laboratory facility, which is worth over 10 million Euro, will allow the company to develop final dosage form for biosimilars and not only active ingredients. As a result, 100 new jobs are going to be created in Mengeš. An important incentive for the development of biosimilars was Sandoz's entry in the US market in 2015.

Sources

  • 21 January 2016: Delo
  • 21 January 2016: Lek (Press release)

Citation

Eurofound (2016), Lek, Business expansion in Slovenia, factsheet number 86249, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/86249.